These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19853701)

  • 21. Usefulness of two-dimensional and speckle tracking echocardiography in "Gray Zone" left ventricular hypertrophy to differentiate professional football player's heart from hypertrophic cardiomyopathy.
    Kansal MM; Lester SJ; Surapaneni P; Sengupta PP; Appleton CP; Ommen SR; Ressler SW; Hurst RT
    Am J Cardiol; 2011 Nov; 108(9):1322-6. PubMed ID: 21855830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of beta-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy.
    Abchee A; Marian AJ
    J Investig Med; 1997 Apr; 45(4):191-6. PubMed ID: 9154300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.
    Patel P; Dhillon A; Popovic ZB; Smedira NG; Rizzo J; Thamilarasan M; Agler D; Lytle BW; Lever HM; Desai MY
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003132. PubMed ID: 26082555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recognition of regional hypertrophy in hypertrophic cardiomyopathy using thallium-201 emission-computed tomography: comparison with two-dimensional echocardiography.
    Suzuki Y; Kadota K; Nohara R; Tamaki S; Kambara H; Yoshida A; Murakami T; Osakada G; Kawai C; Tamaki N
    Am J Cardiol; 1984 Apr; 53(8):1095-102. PubMed ID: 6230927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of left ventricular outflow tract area after septal reduction in obstructive hypertrophic cardiomyopathy: a real-time 3-dimensional echocardiographic study.
    Sitges M; Qin JX; Lever HM; Bauer F; Drinko JK; Agler DA; Kapadia SR; Tuzcu EM; Smedira NG; Lytle BW; Thomas JD; Shiota T
    Am Heart J; 2005 Oct; 150(4):852-8. PubMed ID: 16209993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diastolic dysfunction and its histopathological correlation in obstructive hypertrophic cardiomyopathy in children and adolescents.
    Menon SC; Eidem BW; Dearani JA; Ommen SR; Ackerman MJ; Miller D
    J Am Soc Echocardiogr; 2009 Dec; 22(12):1327-34. PubMed ID: 19815379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy.
    O'Leary TS; Snyder J; Sadayappan S; Day SM; Previs MJ
    J Mol Cell Cardiol; 2019 Feb; 127():165-173. PubMed ID: 30550750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of incidental amyloidosis on the prognosis of patients with hypertrophic cardiomyopathy undergoing septal myectomy for left ventricular outflow tract obstruction.
    Helder MR; Schaff HV; Nishimura RA; Gersh BJ; Dearani JA; Ommen SR; Mereuta OM; Theis JD; Dogan A; Edwards WD
    Am J Cardiol; 2014 Nov; 114(9):1396-9. PubMed ID: 25217455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical hypertrophic cardiomyopathy).
    Maron BJ; Bonow RO; Seshagiri TN; Roberts WC; Epstein SE
    Am J Cardiol; 1982 Jun; 49(8):1838-48. PubMed ID: 6211078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations.
    Maron BJ; Niimura H; Casey SA; Soper MK; Wright GB; Seidman JG; Seidman CE
    J Am Coll Cardiol; 2001 Aug; 38(2):315-21. PubMed ID: 11499718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term follow-up in hypertrophic obstructive cardiomyopathy after septal myectomy.
    Schönbeck MH; Brunner-La Rocca HP; Vogt PR; Lachat ML; Jenni R; Hess OM; Turina MI
    Ann Thorac Surg; 1998 May; 65(5):1207-14. PubMed ID: 9594839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. THE PLACE OF CARDIAC COMPUTED TOMOGRAPHY IN PREOPERATIVE PLANNING OF EXTENDED SEPTAL MYECTOMY IN PATIENTS WITH OBSTRUCTIVE FORM OF HYPERTROPHIC CARDIOMYOMATHY.
    Tregubova MO; Rudenko KB; Lazoryshynets VV; Fedkiv SV; Trembovetskaya OM; Danchenko PA; Vitkovsky YI; Ishchenko MS; Gavrylyshyn AY; Parfentyeva VV; Stukov YY
    Probl Radiac Med Radiobiol; 2020 Dec; 25():592-606. PubMed ID: 33361864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac muscle cell disorganization in apical hypertrophic cardiomyopathy: a cardiac biopsy study.
    Morimoto S; Sekiguchi M; Uemura A; Hiramitsu S; Kimura K; Ohtsuki M; Ishii J; Kato S; Kasanuki H; Hishida H
    Jpn Heart J; 2003 Jul; 44(4):505-13. PubMed ID: 12906032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation of hypertrophic cardiomyopathy from other forms of left ventricular hypertrophy by means of three-dimensional echocardiography.
    Caselli S; Pelliccia A; Maron M; Santini D; Puccio D; Marcantonio A; Pandian NG; De Castro S
    Am J Cardiol; 2008 Sep; 102(5):616-20. PubMed ID: 18721523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
    Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Combined Cox-Maze IV and Ventricular Septal Myectomy for Treatment of Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy.
    Boll G; Rowin EJ; Maron BJ; Wang W; Rastegar H; Maron MS
    Am J Cardiol; 2020 Jan; 125(1):120-126. PubMed ID: 31727261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anatomic and clinical correlates of septal morphology in hypertrophic cardiomyopathy.
    Turer AT; Samad Z; Valente AM; Parker MA; Hayes B; Kim RJ; Kisslo J; Wang A
    Eur J Echocardiogr; 2011 Feb; 12(2):131-9. PubMed ID: 21044981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival Differences in Women and Men After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy.
    Meghji Z; Nguyen A; Fatima B; Geske JB; Nishimura RA; Ommen SR; Lahr BD; Dearani JA; Schaff HV
    JAMA Cardiol; 2019 Mar; 4(3):237-245. PubMed ID: 30810698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elderly patients with hypertrophic cardiomyopathy: a subset with distinctive left ventricular morphology and progressive clinical course late in life.
    Lewis JF; Maron BJ
    J Am Coll Cardiol; 1989 Jan; 13(1):36-45. PubMed ID: 2909578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pattern of left ventricular hypertrophy seen on transthoracic echo in patients with hypertensive cardiomyopathy when compared with idiopathic hypertrophic cardiomyopathy.
    Mirza SJ; Radaideh GA
    J Pak Med Assoc; 2013 Jan; 63(1):16-9. PubMed ID: 23865125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.